MindMed Declares Q2 2021 Financials: US$193.9 Million Total Assets, US$35.6 Million Net Loss

Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced Thursday night its interim financial results for Q2 2021. The biotech company ended the quarter with an incurred net loss of US$35.6 million compared to a loss of US$5.7 million for the same comparable period last year.

The quarter’s net loss translates to US$0.09 per share. A huge slice of the quarterly expenses came from share-based payments amounting to US$21.8 million, a jump from its last year’s figure of US$1.3 million. The increase is mainly due to the stock options issued by the company throughout the period.

The firm increased its cash position during the quarter to end it with a balance of US$157.1 million from US$80.1 million beginning balance. The inflow is impacted by proceeds from the issuance of share capital which amounted to US$81.9 million this quarter.

Total assets landed at US$193.9 million at quarter’s end, US$158.6 of which are current, while current liabilities ended with a balance of US$10.7 million.

In late July 2021, the biotech firm started phase 1 of its clinical trials for intravenous DMT, determining the safety, pharmacokinetics, and pharmacodynamics of the psychedelic substance.

Mind Medicine Inc. last traded at $3.85 on the NEO.


Information for this briefing was found via Sedar and MindMed. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

When 4% of Global Copper Disappears Overnight | David Gower – Emerita Resources

Mining M&A: Gold X2 Acquires Kesselrun Resources

They Said Oil Was Dead. They Were Wrong. | Michael Judson – Record Resources

Recommended

Military Seizes Power in Madagascar After President Flees

Altamira Gold Hits 395.5 Metres Of 0.4 g/t Gold At Maria Bonita

Related News

JR Rahn: Using LSD To Treat Mental Health – The Daily Dive

For our Saturday edition of The Daily Dive, host Cassandra Leah sits down with that...

Saturday, March 20, 2021, 01:30:00 PM

MindMed Closes $34.5 Million Financing, Cash Reserves Said To Be At $85 Million

Mind Medicine (NEO: MMED) has completed its previously announced bought deal private placement, raising gross...

Friday, December 11, 2020, 09:15:15 AM

Mindmed Completes 15-To-1 Reverse Split To Maintain Nasdaq Compliance

Mind Medicine (NEO: MMED) might be slightly more volatile over the next few sessions. The...

Monday, August 29, 2022, 08:21:39 AM

Mind Medicine Boasts Current Cash Position Of US$161 Million

Mind Medicine (NEO: MMED) this morning released its fiscal year 2020 financial results. Given that...

Tuesday, March 30, 2021, 08:19:57 AM

MindMed Declares US$93.0 Million Net Loss, US$133.5 Million Cash Balance For 2021

Mind Medicine Inc. (NEO: MMED), more commonly known as MindMed, announced this morning its financial...

Monday, March 28, 2022, 10:14:00 AM